NLM Logo

fostamatinib MeSH Supplementary Concept Data 2022


MeSH Supplementary
fostamatinib
Unique ID
C523665
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C523665
Entry Term(s)
(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido(3,2-b)-1,4-oxazin-4-yl)methyl disodium phosphate hexahydrate
2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-
2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, sodium salt (1:2)
R-788 free acid
R-788 sodium
R-788 sodium anhydrous
R-788 sodium hydrate
R-935788 free acid
R-935788 sodium anhydrous
R-935788 sodium hydrate
R788 free acid
R788 sodium
R788 sodium anhydrous
R788 sodium hydrate
R935788 free acid
R935788 sodium anhydrous
R935788 sodium hydrate
Tavalisse
fostamatinib disodium
fostamatinib disodium anhydrous
fostamatinib disodium hydrate
fostamatinib disodium salt hexahydrate
Registry Number
SQ8A3S5101
Related Numbers
86EEZ49YVB
X9417132K8
Heading Mapped to
*Aminopyridines
*Morpholines
*Pyrimidines
Frequency
135
Note
a spleen tyrosine kinase (Syk) inhibitor, metabolized to R406
Source
Clin Immunol 2007 Sep;124(3):244-57
Date of Entry
2007/10/22
Revision Date
2021/10/21
fostamatinib Preferred
fostamatinib disodium anhydrous Narrower
fostamatinib disodium hydrate Narrower
R788 free acid Narrower
page delivered in 0.007s